- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BMY
Recent news which mentions BMY
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
From Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
From Benzinga
From Benzinga
From InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
October 12, 2023
From Benzinga
7 Innovator Stocks Primed for Exceptional Growth
October 10, 2023
From InvestorPlace
Why Shares of Lexicon Pharmaceuticals Are Up Tuesday
October 10, 2023
From Motley Fool
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
From Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
October 09, 2023
From Motley Fool
Bristol Myers Squibb Strengthens Oncology Portfolio With Mirati Therapeutics' $5B Deal
October 09, 2023
From Benzinga
S&P 500, Nasdaq Set For Bleak Start To Week As Middle East Tensions Dampen Risk-On Mood: Earnings, Inflation Data In Focus
October 09, 2023
From Benzinga
From $150 oil to no impact at all: What the surprise attack on Israel means to markets
October 09, 2023
From MarketWatch
Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 09, 2023
From Benzinga
Shares in weapons makers Lockheed Martin, RTX surge following surprise attack on Israel and other stocks on the move
October 09, 2023
From MarketWatch
From MarketWatch
2 Growth Stocks That Could Rocket Higher Before the End of 2023
October 08, 2023
From Motley Fool
Bristol-Myers Squibb Unusual Options Activity For October 06
October 06, 2023
Tickers
BMY
From Benzinga
Thinking Of Buying Alexandria Real Estate Equities? Here Are The Properties And Tenants You'd Add To Your Portfolio
October 05, 2023
From Benzinga
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
From Benzinga
Medicare drug price negotiations move forward with all drugmakers participating, White House says
October 03, 2023
From MarketWatch
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
October 02, 2023
From InvestorPlace
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
October 02, 2023
From InvestorPlace
From Benzinga
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
September 29, 2023
From MarketWatch
From Benzinga
3 Dividend Stocks to Buy and Hold Until Retirement
September 28, 2023
From Motley Fool
Bristol-Myers Squibb Unusual Options Activity For September 27
September 27, 2023
Tickers
BMY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.